We provided evidences at first time that JP3 suppressed xenograft tumor growth and metastasis in mouse models; the mechanistic data indicating that JP3 entered GC cells and activated TRIM25, and then increased degradation of SP1, therefore inhibited angiogenesis by reducing transcriptional activation on MMP2. This evidence concerns the gene MMP2 and neoplasm.